Asia-Pacific Biosensors Market

Asia-Pacific Biosensors Market Size, Trends & Growth (2021 - 2026):

The size and share of the Asia-Pacific Biosensors Market are expected to grow in a significant way. It is estimated that the target market is going to get valued around USD 7,184.0 million, recording a CAGR of 9.8% over the forecast period.

Biosensors are devices that are utilized to detect the presence or concentration of a biological analyte, like an anatomical structure or a microorganism, a biomolecule. These biosensors consist of three major parts, which includes a component for recognizing the analyte and produce a signal, a transducer of the message, and a reader device. And the reader device connects through the associated electronics or signal processors which are primarily responsible for the display of the results in a user-friendly way.

The growth of the biosensors market in the Asia-Pacific region is attributed to the rising usage of biosensors to monitor glucose levels in individuals with diabetes and the increasing demand for disposable, cost-efficient & user-friendly devices of the market.

Recent Developments

• LineaRx, Inc., a STONY BROOK N.Y majority-owned subsidiary focused on next-generation biotherapeutics and cancer diagnostics, has announced that they have signed a licensing agreement with LifeSensors, Inc., a significant player in biosensor market, to incorporate LifeSensors’ high expression SUMO-fusion technologies into the Company’s linear DNA amplicons designed and produced for therapeutic applications.

• Johnson & Johnson has announced that its Janssen Pharmaceutical Companies have collaborated with the Beth Israel Deaconess Medical Center to support the development of a preventive vaccine candidate for COVID-19.

Drivers and Restraints of Asia-Pacific Biosensors Market

The significant technological advancements in the field of biosensor technology and the high demand of biosensor in monitoring & diagnostic devices of the market are the major drivers for the growth of the Asia-Pacific biosensor market.

Also, the growing awareness regarding the large population base, clinical outcomes, rise in the geriatric population, growth in diabetic population and technological advancement in medical devices and equipment are the other factors that are boosting the biosensors market in this region.

And the increasing use of biosensors to monitor glucose levels in individuals who are with diabetes along with rising demand for disposable, cost-efficient & user-friendly devices are anticipating the growth of the target market in the Asia-Pacific region during the outlook period.

Market Segmentation of Asia-Pacific Biosensors Market

• Product Type: Non-wearable and Wearable

• Technological Aspect: Electrochemical, Piezoelectric, and Thermal & Optical. The electrochemical segment was further sub-segmented into amperometric sensors, potentiometric sensors and conductometric sensors, where the amperometric sensors are further sub-segmented into blood glucose sensors and Potentiometric sensors are divided into immuno-sensors, penicillin biosensor, and urea biosensor. Among these all the segments, the electrochemical section held for the largest market share and anticipated to reach USD 5476.81 million during the projection period. And the optical section is the segment that was multiplying, at the fastest CAGR of 12.9 % during the forecast period.

• End-User: Point of Care Testing, Home healthcare Diagnostics, Research Laboratories, Food Industry, and Others. And the point of care (POC) is further sub-segmented into glucose monitoring, cardiac markers, infectious diseases, coagulation monitoring, pregnancy & fertility testing, blood gas & electrolytes, tumor or cancer markers, urinalysis testing, cholesterol tests, and others.

• Application: Medical Applications, Cholesterol Testing, Pregnancy Testing, Blood Gas Analyzer, Infectious Diseases, Agriculture, Environment, Food Toxicity, Blood Glucose Monitoring, and Others. Of these, the medical applications accounted for a prominent share in the regional market.

• Region: India, China, Japan, South Korea, Australia & New Zealand, Thailand, Malaysia, Vietnam, Philippines, Indonesia, Singapore & Rest of APAC

In the regional analysis of the Asia-Pacific Biosensors Market, China, Japan, India, Australia, and Others is the area that the market was divided. In all of these regions, Japan accounted for the largest share of Asia Pacific biosensor market revenue. And it is estimated to get valued around USD 2928.16 million over the forecast period. And China is the fastest-growing region which is likely to record a CAGR of 13.0% during the forecasted period.

The key players of the Asia-Pacific biosensors market include the Danaher Corporation, ABBOTT Laboratories, Siemens AG, AGAMATRIX, INC., Bayer AG, Johnson and Johnson, LifeSensors, Inc., Medtronic Plc., Bio-Rad Laboratories, Inc., and Analog Devices, Inc.